BioLok Acquired by Healthpoint Capital
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
TM Capital advised Vention Medical, a leading U.S. full-service medical device outsourcing company, in its acquisition of Ansamed, Ireland’s premier provider of advanced medical tubing solutions
TM Capital served as a financial advisor to Canadian Hospital Specialties, a portfolio company of Cortec Group, in its sale to Flexpoint Ford
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in the strategic acquisition of Irradiation Industries, Inc.
TM Capital served as exclusive financial advisor to GMD PharmaSolutions in its sale to McKesson Corporation (NYSE:MCK)